Contribution of a Video Support to Inform the Patient Before a Complementary Examination in Infectious Diseases
NCT ID: NCT06168448
Last Updated: 2025-04-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
97 participants
OBSERVATIONAL
2023-12-15
2025-02-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Education of Medical Staff to Post Acute Covid susTained sYmptoms
NCT06082258
Treatment's Duration of Acute Uncomplicated Pyelonephritis
NCT00873626
Utility of Empiric Antibiotics for Non-intubated Novel Coronavirus Diseases 2019 Patients
NCT04674410
Prediction of Clinical Course in COVID19 Patients
NCT04377685
An Observational Clinical Study to Evaluate COVID-19 Symptoms in "Long Hauler" Patients Who Participated in K031-120 or K032-120
NCT04814914
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The intention is to introduce a tool that complements the information usually provided, and that can be of high quality to improve the patient's perception of understanding. To this end, investigators hypothesize that a tool in video format, built in collaboration with the experience of various technical platforms, could make the experience of understanding information more complete and more accessible to all patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1 : Patients with oral and written information
Group made up of patients hospitalized at that time in the infectious diseases department who met the eligibility criteria set out in the protocol.
This group of patients will receive the legal oral and written information concerning the additional examination prescribed, as usually delivered by their doctor.
Oral and written information
Legal oral and written information given by physicians concerning additional examinations
Group 2 : Patients with oral and written information + video information
Group made up of patients hospitalized at that time in the infectious diseases department who met the eligibility criteria set out in the protocol.
This group of patients will receive the legal oral and written information concerning the additional examination prescribed, as usually delivered by their physician, and in addition the video tool will be applied to them.
Oral and written information
Legal oral and written information given by physicians concerning additional examinations
Video information
Explanatory video applied after physician's formal information
Group 3 : Caregivers
Nurses and physicians working in the infectious and tropical diseases department.
This group of caregivers will assess the impact of the intervention on their practice.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oral and written information
Legal oral and written information given by physicians concerning additional examinations
Video information
Explanatory video applied after physician's formal information
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* French speaking language
* Hospitalized in the Department of Infectious and Tropical Diseases at Hôpital Necker- Enfants malades
* Prescription, for the first time in its medical history, of one of the following complementary examinations:
* Bronchial FibroscopyIRM
* PICC line insertion
* PET Scanner
* No expressed oral opposition
* Caregiver belonging at nurse or doctor's category
* Caregiver working in the Infectious and Tropical Diseases Department at Necker Hospital
* No expressed oral opposition
* Caregivers who are not in contact with patients
Exclusion Criteria
* Non-French-speaking patient
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fanny LANTERNIER, MD, PhD
Role: STUDY_CHAIR
Assistance Publique - Hôpitaux de Paris
Elisabete GOMES-PIRES, Nurse
Role: PRINCIPAL_INVESTIGATOR
Assistance Publique - Hôpitaux de Paris
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Necker Enfants malades
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-A00266-39
Identifier Type: OTHER
Identifier Source: secondary_id
APHP 230351
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.